CVE-2026-21997
Preserved source conflicts
No provider value was silently selected as the winner.
cwe · 2 assertions
{"cweId":"CWE-284","description":"CWE-284 Improper Access Control","lang":"en","type":"CWE"}
- cve_program_cvelist_v5cweurn:baitaphish:normalized-source-record:v2:5eb9c1d89baed1541e30e350ddb61c656f019f2eba63bc0afc515c8f502011bf · sha256:dfb6fd61e9b59997… · /containers/adp/0/problemTypes/0/descriptions/0
{"description":"Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data.","lang…
- cve_program_cvelist_v5cweurn:baitaphish:normalized-source-record:v2:5eb9c1d89baed1541e30e350ddb61c656f019f2eba63bc0afc515c8f502011bf · sha256:dfb6fd61e9b59997… · /containers/cna/problemTypes/0/descriptions/0
Affected products and versions
1 source assertion{"product":"Oracle Life Sciences Empirica Signal","vendor":"Oracle Corporation","versions":[{"lessThanOrEqual":"9.2.3","status":"affected","version":"9.2.1","versionType":"custom"}]}
- cve_program_cvelist_v5affectedurn:baitaphish:normalized-source-record:v2:5eb9c1d89baed1541e30e350ddb61c656f019f2eba63bc0afc515c8f502011bf · sha256:dfb6fd61e9b59997… · /containers/cna/affected/0
Provider-owned CVSS observations
1 source assertion{"metric":{"attackComplexity":"LOW","attackVector":"NETWORK","availabilityImpact":"NONE","baseScore":8.5,"baseSeverity":"HIGH","confidentialityImpact":"LOW","integrityImpact":"HIGH","privilegesRequired":"LOW","scope":"CHANGED","userInteraction":"NONE","vectorString":"CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N","version":"3.1"},"metric_type":"cvssV3_1"}
- cve_program_cvelist_v5cvssurn:baitaphish:normalized-source-record:v2:5eb9c1d89baed1541e30e350ddb61c656f019f2eba63bc0afc515c8f502011bf · sha256:dfb6fd61e9b59997… · /containers/cna/metrics/0/cvssV3_1
CWE assertions
2 source assertions{"cweId":"CWE-284","description":"CWE-284 Improper Access Control","lang":"en","type":"CWE"}
- cve_program_cvelist_v5cweurn:baitaphish:normalized-source-record:v2:5eb9c1d89baed1541e30e350ddb61c656f019f2eba63bc0afc515c8f502011bf · sha256:dfb6fd61e9b59997… · /containers/adp/0/problemTypes/0/descriptions/0
{"description":"Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data.","lang…
- cve_program_cvelist_v5cweurn:baitaphish:normalized-source-record:v2:5eb9c1d89baed1541e30e350ddb61c656f019f2eba63bc0afc515c8f502011bf · sha256:dfb6fd61e9b59997… · /containers/cna/problemTypes/0/descriptions/0
Source references
1 source assertion{"name":"Oracle Advisory","tags":["vendor-advisory"],"url":"https://www.oracle.com/security-alerts/cpuapr2026.html"}
- cve_program_cvelist_v5referenceurn:baitaphish:normalized-source-record:v2:5eb9c1d89baed1541e30e350ddb61c656f019f2eba63bc0afc515c8f502011bf · sha256:dfb6fd61e9b59997… · /containers/cna/references/0
Attribution and limitations
- CVE Program CVEList V5: Reproduce the MITRE copyright designation and CVE license in copies. Source →
Provider severity values are preserved separately. Baitaphish does not convert them into a risk rating, infer affected products, or treat EPSS as observed exploitation.